Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph G Parambil

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The American Journal of the Medical Sciences|June 16, 2006
Bronchogenic cyst causing atrial fibrillation by impinging the right inferior pulmonary veinJoseph G Parambil, Bernard J Gersh, Mirna Z Knight, et al.
The Laryngoscope|June 23, 2021
Sclerotherapy Versus Cautery/Laser Treatment for Epistaxis in Hereditary Hemorrhagic TelangiectasiaTroy D Woodard, Kathleen B Yappel-Sinkko, Xiaofeng Wang, et al.
Respiratory Medicine|March 23, 2013
A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositisIsabel C Mira-Avendano, Joseph G Parambil, Ruchi Yadav, et al.
Pulmonary Circulation|July 10, 2014
Clinical characterization and survival of patients with borderline elevation in pulmonary artery pressureGustavo A Heresi, Omar A Minai, Adriano R Tonelli, et al.
Mayo Clinic Proceedings|February 14, 2006
Effect of shifting costs to patients on specialty evaluation for sleep disordersJoseph G Parambil, Eric J Olson, John W Shepard, et al.
Angiogenesis|July 22, 2021
Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasiaJoseph G Parambil, James R Gossage, Keith R McCrae, et al.
Angiogenesis|September 8, 2018
Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasiaMarie E Faughnan, James R Gossage, Murali M Chakinala, et al.
American Heart Journal|April 3, 2020
Performance of diagnostic criteria in patients clinically judged to have cardiac sarcoidosis: Is it time to regroup?Manuel L Ribeiro Neto, Christine Jellis, Rory Hachamovitch, et al.
BMC Pulmonary Medicine|June 2, 2022
Prospective cohort of cryobiopsy in interstitial lung diseases: a single center experienceManuel L Ribeiro Neto, Andrea Valeria Arrossi, Ruchi Yadav, et al.
Haematologica|July 18, 2020
An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed studyHanny Al-Samkari, Raj S Kasthuri, Joseph G Parambil, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The American Journal of the Medical Sciences|June 16, 2006
Bronchogenic cyst causing atrial fibrillation by impinging the right inferior pulmonary veinJoseph G Parambil, Bernard J Gersh, Mirna Z Knight, et al.
The Laryngoscope|June 23, 2021
Sclerotherapy Versus Cautery/Laser Treatment for Epistaxis in Hereditary Hemorrhagic TelangiectasiaTroy D Woodard, Kathleen B Yappel-Sinkko, Xiaofeng Wang, et al.
Respiratory Medicine|March 23, 2013
A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositisIsabel C Mira-Avendano, Joseph G Parambil, Ruchi Yadav, et al.
Pulmonary Circulation|July 10, 2014
Clinical characterization and survival of patients with borderline elevation in pulmonary artery pressureGustavo A Heresi, Omar A Minai, Adriano R Tonelli, et al.
Mayo Clinic Proceedings|February 14, 2006
Effect of shifting costs to patients on specialty evaluation for sleep disordersJoseph G Parambil, Eric J Olson, John W Shepard, et al.
Angiogenesis|July 22, 2021
Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasiaJoseph G Parambil, James R Gossage, Keith R McCrae, et al.
Angiogenesis|September 8, 2018
Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasiaMarie E Faughnan, James R Gossage, Murali M Chakinala, et al.
American Heart Journal|April 3, 2020
Performance of diagnostic criteria in patients clinically judged to have cardiac sarcoidosis: Is it time to regroup?Manuel L Ribeiro Neto, Christine Jellis, Rory Hachamovitch, et al.
BMC Pulmonary Medicine|June 2, 2022
Prospective cohort of cryobiopsy in interstitial lung diseases: a single center experienceManuel L Ribeiro Neto, Andrea Valeria Arrossi, Ruchi Yadav, et al.
Haematologica|July 18, 2020
An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed studyHanny Al-Samkari, Raj S Kasthuri, Joseph G Parambil, et al.
Pageof 3